Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aurora kinase B pseudogene 1 (AURKBP1) is a non-coding pseudogene related to the aurora kinase B (AURKB) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they may arise from gene duplication or retrotransposition events. AURKBP1 does not encode an active enzyme or receptor protein, nor does it have direct functional roles in cell cycle or cancer, unlike the functional aurora kinase B. There is no evidence supporting its involvement as a direct therapeutic target, nor are there known interacting drugs or established disease associations. Some pseudogenes can have subtle regulatory functions at the RNA level, but there are no known biological or pharmacological roles for AURKBP1 specifically. Important context: This entry is often confused with the true aurora kinase B (AURKB), an enzyme with essential roles in mitosis/cell cycle and significant involvement in cancer biology, which is a validated therapeutic target. AURKBP1 is a pseudogene as noted in authoritative sources, and no data indicate it encodes an active protein or functions as a target for drugs or diagnostics. If you are seeking information about the active kinase (therapeutic target), you should refer to aurora kinase B (AURKB), which is involved in cell cycle regulation, is overexpressed in cancer, and is targeted by several kinase inhibitors in clinical research and therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aurora kinase B pseudogene 1 (AURKBP1).